Our publications

EPI-PHARE disseminates its results to French Health Authorities, in the form of public reports, and publishes them in international peer-reviewed scientific journals.

Search by
Type of study
  • Benefits and risks of health products
  • Methods and tools
  • Response to alerts or crisis
  • Use of health products in real life
Keyword
  • Aids
  • Alert or crisis situation
  • AMR
  • Anti-infective
  • Anti-TNF
  • Anti-VEGF
  • Antibiotics
  • Antiepileptic drugs
  • Antihypertensive drugs
  • Aspirin
  • Biologics
  • Biosimilar
  • Breast cancer
  • Cancer
  • Chemotherapy
  • Children
  • Chlormadinone acetate
  • Codeine
  • Colonoscopy
  • Confinement
  • Contraception
  • Covid-19
  • Cyproterone acetate
  • Elderly people
  • Epidemic
  • Finasteride
  • Hydroxychloroquine
  • Immunosuppressive drugs
  • Inflammatory bowel disease
  • Levothyrox
  • Massive exposure
  • Medical devices
  • Meningioma
  • Multiple sclerosis
  • Mycophenolate
  • Nomegestrol acetate
  • Ophthalmology
  • Oral anticoagulants
  • PPI
  • Pregnancy
  • PrEP
  • Progestogens
  • Prophylaxis
  • Proton pump inhibitors
  • Psoriasis
  • Rheumatoid arthritis
  • Rituximab
  • Specific population
  • Statins
  • Statistics
  • Suicide
  • Transplant
  • Trastuzumab
  • Truvada
  • Vaccines
  • Valproate
  • Valsartan
  • VIH
  • Women of childbearing age
Period
Afficher plus